2seventy bio CEO to step down, plans job cuts
Sept 12 (Reuters) - Cell and gene therapy company
2seventy bio TSVT.O said on Tuesday that CEO Nick Leschly will
step down.
The company also said it plans to lay off about 40% of its
current workforce.
(Reporting by Pratik Jain in Bengaluru; Editing by Shounak
Dasgupta)
((Pratik.Jain@thomsonreuters.com))
Recent news on 2Seventy Bio
See all news2Seventy Bio Inc expected to post a loss of 17 cents a share - Earnings Preview
2Seventy Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: 2Seventy Bio Q4 Basic EPS USD -0.37
2Seventy Bio Inc expected to post a loss of 26 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney